Adicet Bio Reports Q3 2026 Financial Results (Aug 5, 2026)

What Happened

• Adicet Bio, Inc. announced its financial results for the quarter ended June 30, 2026 and furnished a related press release on August 5, 2026. The company filed a Current Report on Form 8-K (Item 2.02) to disclose these quarterly results; the press release is included as Exhibit 99.1.
• The 8-K specifies that the information is being furnished (not “filed”) under the Securities Exchange Act and therefore is not subject to Section 18 liability or automatically incorporated by reference into other filings. The report was signed by Chief Financial Officer Nick Harvey.

Key Details

• Company: Adicet Bio, Inc. (ACET).
• Event: Quarterly financial results reported for the period ended June 30, 2026.
• Filing date: August 5, 2026; press release furnished as Exhibit 99.1 to the Form 8-K.
• Disclosure status: Information furnished (not deemed “filed”) under the Exchange Act.

Why It Matters

• Quarterly results are a primary source of updated information on earnings, revenue, expenses and financial condition; investors should review the furnished press release for the detailed metrics and any management commentary or guidance.
• Because the 8-K furnishes (rather than files) the release, investors should rely on the press release itself for the disclosed figures and monitor subsequent filings (e.g., quarterly 10-Q) for audited or more detailed financial statements.